Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

PubWeight™: 2.96‹?› | Rank: Top 1%

🔗 View Article (PMID 23921906)

Published in JAMA Intern Med on October 14, 2013

Authors

Samir Gupta, Ethan A Halm, Don C Rockey, Marcia Hammons, Mark Koch, Elizabeth Carter, Luisa Valdez, Liyue Tong, Chul Ahn, Michael Kashner, Keith Argenbright, Jasmin Tiro, Zhuo Geng, Sandi Pruitt, Celette Sugg Skinner

Associated clinical trials:

Increasing Colorectal Cancer Screening in a Safety-net Health System With a Focus on the Uninsured: Benefits and Costs | NCT01191411

Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE) (SCORE) | NCT04406714

Articles citing this

Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61

Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst (2014) 1.53

The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev (2014) 1.30

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer (2015) 1.25

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials (2014) 1.19

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10

Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial. J Gen Intern Med (2015) 1.08

Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA (2017) 1.05

Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice. Int J Cancer (2014) 0.97

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med (2016) 0.97

Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97

Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States. Cancer (2014) 0.96

Colorectal cancer disparities: issues, controversies and solutions. World J Gastroenterol (2014) 0.95

Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev (2013) 0.92

Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med (2014) 0.91

Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer (2015) 0.90

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.85

Physicians, clinics, and neighborhoods: multiple levels of influence on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2014) 0.84

Neighborhood effects in a behavioral randomized controlled trial. Health Place (2014) 0.80

Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health (2015) 0.79

Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol (2016) 0.79

Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol (2016) 0.78

Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case-control study. Int J Colorectal Dis (2014) 0.78

E-mail to Promote Colorectal Cancer Screening Within Social Networks: Acceptability and Content. J Health Commun (2015) 0.77

Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med (2016) 0.77

Third Annual Fecal Occult Blood Testing in Community Health Clinics. Am J Health Behav (2016) 0.77

A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer (2016) 0.77

Financial Incentives for Promoting Colorectal Cancer Screening: A Randomized, Comparative Effectiveness Trial. Am J Gastroenterol (2016) 0.76

Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma. Gastroenterology (2016) 0.76

Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Prev Med (2013) 0.76

Dedicated outreach is effective in increasing uptake of colorectal cancer screening in an underserved population. Gastroenterology (2013) 0.75

Recruiting community health centers into pragmatic research: Findings from STOP CRC. Clin Trials (2015) 0.75

Editorial: Financial Incentives to Improve Colorectal Cancer Screening: Does it Make Cents? Am J Gastroenterol (2016) 0.75

Mailed invitations for colorectal screening are effective in increasing screening participation in uninsured adults with faecal immunochemical testing: the preferred screening modality. Evid Based Med (2014) 0.75

Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol (2016) 0.75

Rapid review of evaluation of interventions to improve participation in cancer screening services. J Med Screen (2016) 0.75

Community-Based Colorectal Cancer Screening in a Rural Population: Who Returns Fecal Immunochemical Test (FIT) Kits? J Rural Health (2016) 0.75

Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea. Gut Liver (2017) 0.75

Optimizing the Quality of the Colorectal Cancer Screening Continuum: A Call to Action. J Natl Cancer Inst (2017) 0.75

A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer (2017) 0.75

Articles cited by this

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Primary care: is there enough time for prevention? Am J Public Health (2003) 15.81

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer (2010) 13.27

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79

Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78

A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med (2009) 3.48

Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med (2011) 3.27

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut (2008) 3.25

A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust (2006) 3.20

A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer (2007) 2.64

Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62

Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med (2008) 2.14

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst (2004) 1.96

Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev (2011) 1.90

Colorectal cancer screening: clinical applications. JAMA (2003) 1.74

Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med (2010) 1.46

Colorectal cancer screening among underserved Korean Americans in Los Angeles County. J Immigr Minor Health (2008) 1.39

Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer (2010) 1.32

NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements (2010) 1.30

America's health care safety net: revisiting the 2000 IOM report. Health Aff (Millwood) (2007) 1.18

Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices. J Am Board Fam Med (2012) 1.17

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol (2012) 1.16

Mailed fecal-immunochemical test for colon cancer screening. J Community Health (2010) 1.14

Why hasn't this patient been screened for colon cancer? An Iowa Research Network study. J Am Board Fam Med (2007) 1.13

Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial. Ann Fam Med (2012) 0.99

Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care (2012) 0.95

Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence. J Gastroenterol Hepatol (2008) 0.90

Will test-specific adherence predict the best colorectal cancer screening strategy? Ann Intern Med (2009) 0.85

Policy Framework for Covering Preventive Services Without Cost Sharing: Saving Lives and Saving Money? JAMA Intern Med (2016) 0.82

Articles by these authors

Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet (2007) 4.93

Fibrosis--a common pathway to organ injury and failure. N Engl J Med (2015) 3.94

An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care (2010) 3.71

Association of timing of surgery for hip fracture and patient outcomes. JAMA (2004) 3.51

Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med (2012) 2.67

Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol (2005) 2.45

Prospective comparison of patient experience with colon imaging tests. Am J Med (2006) 2.42

Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg (2010) 2.35

Predictors of endoscopic and laboratory evaluation of iron deficiency anemia in hospitalized patients. South Med J (2007) 2.20

Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med (2009) 2.12

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology (2002) 2.10

Upper gastrointestinal bleeding caused by severe esophagitis: a unique clinical syndrome. Dig Dis Sci (2014) 1.98

Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96

Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf (2013) 1.94

Loss of Insl3: a potential predisposing factor for testicular torsion. J Urol (2010) 1.93

Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol (2009) 1.92

Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc (2008) 1.85

Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study. BMJ (2011) 1.84

CT colonography: false-negative interpretations. Radiology (2007) 1.84

Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev (2006) 1.81

Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax (2010) 1.80

Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effect on outcomes. J Am Geriatr Soc (2003) 1.78

Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial. Ann Intern Med (2011) 1.78

A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med (2005) 1.74

Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation (2003) 1.70

Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69

Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care. Med Care (2007) 1.65

Safety and utility of ERCP during pregnancy. Gastrointest Endosc (2009) 1.65

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers. Hepatology (2012) 1.64

Comparison of tailored interventions to increase mammography screening in nonadherent older women. Prev Med (2003) 1.64

Primary closure of the carotid artery is associated with poorer outcomes during carotid endarterectomy. J Vasc Surg (2005) 1.63

Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev (2004) 1.62

Hospitalizations for pediatric stone disease in United States, 2002-2007. J Urol (2010) 1.62

Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61

Patient relocation in the 6 months after hip fracture: risk factors for fragmented care. J Am Geriatr Soc (2004) 1.60

EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem (2007) 1.59

Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med (2006) 1.57

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health (2003) 1.57

The impact of consenter characteristics and experience on patient interest in clinical research. Oncologist (2009) 1.57

Modestly increased use of colonoscopy when copayments are waived. Clin Gastroenterol Hepatol (2012) 1.56

Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health (2004) 1.55

Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma. Prim Care Respir J (2011) 1.55

Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol (2008) 1.54

Sociocultural correlates of breast cancer knowledge and screening in urban African American women. Am J Public Health (2003) 1.53

Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition. J Pediatr (2005) 1.53

Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology (2002) 1.52

Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea. JAMA Dermatol (2013) 1.51

Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther (2007) 1.51

Predictors of mortality, rehospitalization for syncope, and cardiac syncope in 352 consecutive elderly patients with syncope. J Am Med Dir Assoc (2013) 1.49

Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) (2012) 1.49

Health literacy and cognitive performance in older adults. J Am Geriatr Soc (2009) 1.49

Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol (2006) 1.47

The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int (2003) 1.47

Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol (2009) 1.46

A breast cancer fear scale: psychometric development. J Health Psychol (2004) 1.45

Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome. Liver Transpl (2013) 1.44

Pain predicts non-adherence to pap smear screening among middle-aged African American women. Prev Med (2005) 1.43

Change in care among nonenrolled patients during and after a randomized trial. Pediatrics (2013) 1.42

Proton pump inhibitors in acute peptic ulcer bleeding. Gastroenterology (2005) 1.42

Responses to behaviorally vs culturally tailored cancer communication among African American women. Am J Health Behav (2004) 1.42

Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat Med (2003) 1.42

Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3. J Hepatol (2013) 1.40

Development of a self-efficacy scale for mammography. Res Nurs Health (2005) 1.40

Resection and free tissue reconstruction of locally advanced oral cancer: avoidance of lip split. Microsurgery (2011) 1.40

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology (2005) 1.40

Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol (2013) 1.39

Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther (2007) 1.38

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology (2007) 1.37

Studying communication in oncologist-patient encounters: the SCOPE Trial. Palliat Med (2006) 1.37

A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns (2008) 1.36

Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum (2007) 1.33

Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control (2009) 1.32

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol (2010) 1.31

A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health (Larchmt) (2004) 1.31

Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt. J Biol Chem (2003) 1.29

Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res (2008) 1.29

The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci (2007) 1.28

Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol (2007) 1.28

Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev (2004) 1.27

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. BMC Cardiovasc Disord (2012) 1.26

Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns (2008) 1.26

Endothelin--biology and disease. Cell Signal (2010) 1.26

Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.25

Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol (2011) 1.24

Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv (2007) 1.23

Comparisons of tailored mammography interventions at two months postintervention. Ann Behav Med (2002) 1.22

Barriers to adherence to asthma management guidelines among inner-city primary care providers. Ann Allergy Asthma Immunol (2008) 1.21

Differences in perceptions of risk, benefits, and barriers by stage of mammography adoption. J Womens Health (Larchmt) (2003) 1.20

Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol (2015) 1.19

Identification and functional characterization of TMEM16A, a Ca2+-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium. J Biol Chem (2010) 1.19

Assessing the relationship between language proficiency and asthma morbidity among inner-city asthmatics. Med Care (2009) 1.15

Plasma apolipoprotein L1 levels do not correlate with CKD. J Am Soc Nephrol (2013) 1.15

Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg (2008) 1.15

Metabolic disturbances associated with systemic lupus erythematosus. PLoS One (2012) 1.15

Acute pancreatitis during pregnancy. Clin Gastroenterol Hepatol (2009) 1.14

How many measurements for time-averaged differences in repeated measurement studies? Contemp Clin Trials (2011) 1.14

Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.13